Insider Transactions in Q4 2023 at Dexcom Inc (DXCM)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2023
|
Barry J. Regan EVP Operations |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,675
-2.79%
|
$202,675
$121.85 P/Share
|
|
Dec 18
2023
|
Jereme M Sylvain EVP, Chief Financal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,932
-4.02%
|
$354,772
$121.85 P/Share
|
|
Dec 18
2023
|
Sadie Stern EVP, Chief HR Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,675
-2.2%
|
$202,675
$121.85 P/Share
|
|
Dec 18
2023
|
Jacob Steven Leach EVP, Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,932
-1.13%
|
$354,772
$121.85 P/Share
|
|
Dec 18
2023
|
Paul R Flynn EVP Global Revenue |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,163
-6.07%
|
$382,723
$121.85 P/Share
|
|
Dec 15
2023
|
Steven R Altman Director |
SELL
Open market or private sale
|
Indirect |
2,000
-3.53%
|
$244,000
$122.77 P/Share
|
|
Dec 15
2023
|
Nicholas Augustinos Director |
SELL
Open market or private sale
|
Indirect |
3,976
-10.46%
|
$489,048
$123.02 P/Share
|
|
Dec 12
2023
|
Steven R Altman Director |
SELL
Open market or private sale
|
Indirect |
3,000
-5.03%
|
$360,000
$120.0 P/Share
|
|
Dec 11
2023
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
392
-0.51%
|
$45,864
$117.66 P/Share
|
|
Dec 01
2023
|
Michael Jon Brown EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,612
-1.98%
|
$411,768
$114.5 P/Share
|
|
Nov 24
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
411
-0.33%
|
$45,210
$110.8 P/Share
|
|
Nov 22
2023
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
1,176
-1.52%
|
$129,360
$110.0 P/Share
|
|
Nov 19
2023
|
Barry J. Regan EVP Operations |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,106
-6.39%
|
$427,024
$104.06 P/Share
|
|
Nov 19
2023
|
Sadie Stern EVP, Chief HR Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,106
-5.03%
|
$427,024
$104.06 P/Share
|
|
Nov 15
2023
|
Steven R Altman Director |
SELL
Open market or private sale
|
Indirect |
1,000
-1.65%
|
$101,000
$101.26 P/Share
|
|
Nov 09
2023
|
Girish Naganathan EVP Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,725
-5.4%
|
$253,425
$93.27 P/Share
|
|
Nov 08
2023
|
Barry J. Regan EVP Operations |
SELL
Open market or private sale
|
Direct |
2,019
-3.05%
|
$191,805
$95.22 P/Share
|
|
Oct 23
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
411
-0.33%
|
$34,935
$85.75 P/Share
|
|
Oct 16
2023
|
Steven R Altman Director |
SELL
Open market or private sale
|
Indirect |
1,000
-1.62%
|
$77,000
$77.58 P/Share
|